Shares of Lucid Diagnostics (NASDAQ:LUCD) fell over 14% premarket on Tuesday after the corporate launched a inventory providing to lift roughly $15.3M in gross proceeds.
The diagnostics firm has entered into subscription agreements with sure accredited traders to promote 13.94M shares of widespread inventory at $1.10 a share. It can use the web proceeds from this providing for working capital and different basic company functions.
Supply: Press Launch
